These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16188006)

  • 1. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
    Degenring RF; Jonas JB
    Acta Ophthalmol Scand; 2005 Oct; 83(5):621. PubMed ID: 16188006
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
    Ho TC
    Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
    Marticorena J; Gomez-Ulla F; Fernandez M; Pazos B; Rodriguez-Cid MJ; Sanchez-Salorio M
    Am J Ophthalmol; 2006 Aug; 142(2):335-7. PubMed ID: 16876524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.
    Potter MJ; Szabo SM; Ho T
    Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):639-41. PubMed ID: 16175378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide.
    Peiretti E; Klancnik JM; Spaide RF; Yannuzzi L
    Retina; 2005; 25(3):377-9. PubMed ID: 15805922
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease.
    Nóbrega M; Bortolotto C; Farah M
    Can J Ophthalmol; 2007 Oct; 42(5):761-2. PubMed ID: 17891211
    [No Abstract]   [Full Text] [Related]  

  • 10. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Retina; 2005 Sep; 25(6):685-90. PubMed ID: 16141854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
    Chan WM; Lai TY; Lau TT; Lee VY; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
    Liggett PE; Colina J; Chaudhry NA; Tom D; Haffner G
    Am J Ophthalmol; 2006 Dec; 142(6):1072-4. PubMed ID: 17157599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.
    Roth DB; Kulkarni KM; Feuer WJ
    Ophthalmic Surg Lasers Imaging; 2008; 39(1):12-6. PubMed ID: 18254345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
    Schmidt-Erfurth U; Michels S; Augustin A
    Arch Ophthalmol; 2006 Apr; 124(4):561-3. PubMed ID: 16606885
    [No Abstract]   [Full Text] [Related]  

  • 18. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial.
    Maberley D;
    Ophthalmology; 2009 Nov; 116(11):2149-57.e1. PubMed ID: 19748675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should corticosteroids be considered as part of the standard care with photodynamic therapy?
    Zarbin M
    Arch Ophthalmol; 2006 Apr; 124(4):563-71. PubMed ID: 16606886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.